Life-saving percutaneous intervention in young patient with massive pulmonary embolism

Area of Science:

• Cardiology
• Vascular Medicine
• Interventional Radiology

Background:

• Massive pulmonary embolism (PE) presents a significant mortality risk, particularly in younger patients.
• Current treatment options for massive PE, including surgery and thrombolysis, have limitations and risks.
• Percutaneous interventions offer an alternative for selected patients, especially those with contraindications to thrombolysis.

Observation:

• A 23-year-old male presented with a first-episode massive PE.
• The patient had an underlying diagnosis of protein C deficiency, a risk factor for venous thromboembolism.
• Initial treatment strategies for massive PE were considered due to bleeding risks.

Findings:

• The patient was successfully treated with a combined approach of systemic thrombolysis and percutaneous interventions.
• This combined strategy effectively managed the massive PE in a young patient with a rare underlying condition.
• No randomized trials currently validate percutaneous intervention for massive PE, highlighting the need for further research.

Implications:

• This case suggests that a combined percutaneous and thrombolytic approach may be a viable option for massive PE in specific patient populations.
• Further research, including randomized controlled trials, is needed to establish the efficacy and safety of percutaneous interventions in massive PE.
• Understanding the role of genetic factors like protein C deficiency in PE is crucial for tailored treatment strategies.